|
Peruvian clinical trial registry identifier
|
CTO_0000004 |
|
|
Australian New Zealand clinical trials registry
|
CTO_0000003 |
|
|
Australian New Zealand clinical trials registry identifier
|
CTO_0000002 |
|
|
condition
|
PDRO_0000129 |
|
|
secondary identifier
|
CTO_0000001 |
|
|
secondary outcome measure information
|
CTO_0000008 |
|
|
selection criterion
|
OBI_0001755 |
|
|
study summary result
|
CTO_0000007 |
|
|
non-random allocation
|
CTO_0000006 |
|
|
Clinical Study Sponsor
|
NCIT_C70793 |
|
|
Sponsor
|
NCIT_C48355 |
|
|
Iranian registry of clinical trials
|
CTO_0000009 |
|
|
Mammalia
|
NCBITaxon_40674 |
|
|
Patient Registry Study
|
NCIT_C129000 |
|
|
Observational Study
|
NCIT_C16084 |
|
|
clinical finding
|
OGMS_0000014 |
|
|
clinical history
|
OGMS_0000015 |
|
|
history
|
BFO_0000182 |
|
|
process
|
BFO_0000015 |
|
|
preclinical finding
|
OGMS_0000019 |
|
